Not recruiting
Chronic kidney disease+1
Not recruitingA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
Investigational
A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
Investigational
- Disease:Chronic kidney diseaseArteriosclerosis
- Substances:Ziltivekimab
Countries:
Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Ziltivekimab
- Sponsor:Novo Nordisk A/S



